U.S. senator taken to hospital: Stroke confirmed.
U.S. Democratic Senator Chris Murphy from Connecticut was taken to hospital after feeling numbness in his arm on October 31. It was reported that the 53‑year‑old senator, who suffered a stroke, is conscious and treatment is ongoing.
U.S. Democratic Senator Chris Murphy from Connecticut was taken to the hospital after a health issue. On October 31, the 53‑year‑old senator, who felt numbness in his arm, was found to have suffered a stroke after tests. It was reported that Murphy remained conscious and was receiving treatment.
Statement Issued from His Private Office
Senator Murphy's private office, Allison Herwitt, in a written statement said that Murphy felt numbness in his arm on October 31 and was later taken to the hospital.
Herwitt recorded that after tests conducted in the hospital it was determined that Murphy had suffered a stroke, and that the senator remained conscious and was under treatment.
Had Been in the Spotlight Over an Iran Statement
Before his health issue, Chris Murphy had entered the news with his remarks about possible attack plans against Iran.
Murphy, stating that he had been briefed on the attack plans by a group of senators, described the plans as "crazy" in a statement on October 29.
Comments
You must sign in to comment.
Sign InYou Might Also Like
Cyber attack alarm in Europe! Thousands of products destroyed
Cyber attacks targeting well-known retail chains in France disabled the cold chain infrastructure, leading to the destruction of thousands of products. The spread of the attack wave across Europe has raised concerns.
A Turkish Signature on New York Streets! Global Giants Are Knocking on His Door
The journey that began on New York streets with an ice‑cream truck extended into advertising campaigns for global brands! Turkish entrepreneur Eddie Emin Cömert draws attention with vehicles specially outfitted for brands such as Sephora. Cömert, who has made headlines with vehicles visited by Cristiano Ronaldo’s partner Georgina Rodriguez, continues to grow in ABD with a fleet of more than 50 vehicles.
Historic Step in Cancer Treatment by a Turkish Scientist!
The cancer drug candidate developed under the leadership of Turkish scientist Prof. Dr. Rana Sanyal has surpassed an important milestone. Targeting the reduction of chemotherapy side effects and delivering the drug directly to the tumor site, RS-0139 has completed its first clinical phase. In a study that began in Turkey and is planned to be moved to international research, the focus has now shifted to 2027.
.avif){kind=small}